×

Bristol-Myers falls on kidney cancer drug trial results

4:56 PM ET Tue, 15 Aug 2017

CNBC's Meg Tirrell reports on Bristol-Myers falling after its kidney cancer drug trial results. Also, more on Merck's CEO's decision to leave the President's manufacturing council.